Patents by Inventor Jeffrey Lyle Gray

Jeffrey Lyle Gray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8188125
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Grant
    Filed: May 18, 2009
    Date of Patent: May 29, 2012
    Assignee: Aerpio Therapeutics Inc.
    Inventors: Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Publication number: 20120077853
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Application
    Filed: December 1, 2011
    Publication date: March 29, 2012
    Inventors: Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Publication number: 20120077975
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Application
    Filed: December 1, 2011
    Publication date: March 29, 2012
    Inventors: Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Patent number: 8106078
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Grant
    Filed: August 4, 2010
    Date of Patent: January 31, 2012
    Assignee: Warner Chilcott Company, LLC
    Inventors: Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Patent number: 7795444
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Grant
    Filed: June 26, 2007
    Date of Patent: September 14, 2010
    Assignee: Warner Chilcott Company
    Inventors: Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Publication number: 20100069448
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Application
    Filed: November 23, 2009
    Publication date: March 18, 2010
    Inventors: Jeffrey Lyle Gray, Kande K.D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Publication number: 20100016336
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Application
    Filed: September 11, 2009
    Publication date: January 21, 2010
    Inventors: Jeffrey Lyle Gray, Kande K.D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Patent number: 7622593
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Grant
    Filed: June 26, 2007
    Date of Patent: November 24, 2009
    Assignee: The Procter & Gamble Company
    Inventors: Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Patent number: 7589212
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Grant
    Filed: June 26, 2007
    Date of Patent: September 15, 2009
    Assignee: Procter & Gamble Company
    Inventors: Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Publication number: 20090227639
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Application
    Filed: May 18, 2009
    Publication date: September 10, 2009
    Inventors: Jeffrey Lyle Gray, Kande K.D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Patent number: 7482454
    Abstract: This invention relates to novel antimicrobial compounds of formula; wherein X, R1, R3, R5, R6, and R8 are defined in the claims, and to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically-acceptable salts, hydrates, and biohydrolyzable esters, amides and imides thereof, and to compositions and uses of such compounds. The invention also relates to compounds derived from these compounds having antimicrobial uses.
    Type: Grant
    Filed: December 13, 2005
    Date of Patent: January 27, 2009
    Assignee: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Patent number: 6900224
    Abstract: Compounds of the following formula: are effective antimicrobial agents.
    Type: Grant
    Filed: June 16, 2003
    Date of Patent: May 31, 2005
    Assignee: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Xiufeng Eric Hu, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Patent number: 6849740
    Abstract: Compounds having the general structure which are effective antimicrobial agents.
    Type: Grant
    Filed: March 18, 2003
    Date of Patent: February 1, 2005
    Assignee: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Publication number: 20040167183
    Abstract: Compounds of formula (I): 1
    Type: Application
    Filed: August 4, 2003
    Publication date: August 26, 2004
    Applicant: The Procter & Gamble Company
    Inventors: Sean Rees Klopfenstein, Matthew Brian Maier, David Robert Jones, Jeffrey Lyle Gray, Matthew Eugene Pokross, Kevin Gene Peters, Artem Gennady Evdokimov
  • Publication number: 20040038975
    Abstract: Compounds of the following formula: 1
    Type: Application
    Filed: June 16, 2003
    Publication date: February 26, 2004
    Applicant: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Xiufeng Eric Hu, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Publication number: 20040029882
    Abstract: Compounds of the following formula: 1
    Type: Application
    Filed: July 30, 2003
    Publication date: February 12, 2004
    Applicant: The Procter & Gamble Co.
    Inventors: Benoit Ledoussal, Xiufeng Eric Hu, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Patent number: 6645981
    Abstract: Compounds of the following formula: are effective antimicrobial agents.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: November 11, 2003
    Assignee: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Xiufeng Eric Hu, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Publication number: 20030207862
    Abstract: Compounds having the general structure: 1
    Type: Application
    Filed: March 19, 2003
    Publication date: November 6, 2003
    Applicant: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Publication number: 20030008894
    Abstract: Compounds of the following formula: 1
    Type: Application
    Filed: December 14, 2001
    Publication date: January 9, 2003
    Applicant: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Xiufeng Eric Hu, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Publication number: 20020173501
    Abstract: Compounds having the general structure: 1
    Type: Application
    Filed: February 28, 2002
    Publication date: November 21, 2002
    Applicant: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Ji-In Kim Almstead, Jeffrey Lyle Gray